Osteoclasts in myeloma are derived from Gr-1+CD11b+mononuclear cells of the bone marrow niche

Osteoclasts in myeloma are derived from Gr-1+CD11b+mononuclear cells of the bone marrow niche

Bibliographic Details
Main Authors:	Zhuang, J, Yang, L, Edwards, JR, Edwards, C, Mundy, G
Format:	Conference item
Published:	2007

Similar Items

Osteoclasts in Myeloma Are Derived from Gr-1(+)CD11b(+) Myeloid Immune Suppressor Cells of the Bone Marrow Niche in Vivo
by: Zhuang, J, et al.
Published: (2008)

Osteoclasts in multiple myeloma are derived from Gr-1+CD11b+myeloid-derived suppressor cells
by: Zhuang, J, et al.
Published: (2012)

Decreased bone marrow-derived adiponectin contributes to myeloma pathogenesis in vivo
by: Fowler, J, et al.
Published: (2010)

Host Bone Marrow-Derived Stromal Cells Promote Myeloma Initiation and Development of Osteolysis
by: Fowler, J, et al.
Published: (2008)

Gr-1+CD11b+ myeloid-derived suppressor cells: formidable partners in tumor metastasis.
by: Yang, L, et al.
Published: (2010)

The Bone Marrow Microenvironment in Multiple Myeloma
by: Edwards, C
Published: (2010)

The importance of the bone marrow microenvironment in multiple myeloma; Differential responses to lithium in vivo
by: Edwards, C, et al.
Published: (2006)

Bone marrow adiposity and multiple myeloma
by: Morris, E, et al.
Published: (2018)

The pathogenesis of the bone disease of multiple myeloma.
by: Edwards, C, et al.
Published: (2008)

Osteoclasts promote the formation of hematopoietic stem cell niches in the bone marrow.
by: Mansour, A, et al.
Published: (2012)

Morphogens and growth factor signalling in the myeloma bone-lining niche
by: Morris, EV, et al.
Published: (2021)

Zoledronic Acid Inhibits the Capacity of Myeloid-Immune Suppressor Cells in Myeloma to Form Osteoclasts.
by: Zhuang, J, et al.
Published: (2008)

Targeting Wnt signaling in myeloma in vivo; Differential effects on tumor burden and myeloma bone disease
by: Edwards, C, et al.
Published: (2007)

Myeloma cells exhibit an increase in proteasome activity and an enhanced response to proteasome inhibition in the bone marrow microenvironment in vivo.
by: Edwards, C, et al.
Published: (2009)

Increasing Wnt signaling in the bone marrow microenvironment inhibits the development of myeloma bone disease and reduces tumor burden in bone in vivo.
by: Edwards, C, et al.
Published: (2008)

Osteoclast precursors at sites of pathological bone resorption are CD14+mononuclear phagocytes
by: Danks, L, et al.
Published: (2001)

Adipokines, adiposity, and bone marrow adipocytes: Dangerous accomplices in multiple myeloma
by: Morris, E, et al.
Published: (2018)

Myeloma cells decrease EphB4 expression in osteoblasts; A novel mechanism for regulation of bone formation in multiple myeloma
by: Bates, A, et al.
Published: (2007)

Myeloma cells decrease EphB4 expression in osteoblasts: A novel mechanism for regulation of bone formation in multiple myeloma
by: Bates, A, et al.
Published: (2007)

Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1.
by: Fowler, J, et al.
Published: (2012)

CD14- mononuclear stromal cells support (CD14+) monocyte-osteoclast differentiation in aneurysmal bone cyst.
by: Taylor, R, et al.
Published: (2012)

Lithium inhibits the development of myeloma bone disease in vivo.
by: Edwards, C, et al.
Published: (2006)

Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease
by: Gooding, S, et al.
Published: (2019)

Bone vasculature and bone marrow vascular niches in health and disease
by: Chen, J, et al.
Published: (2020)

Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease.
by: Fowler, J, et al.
Published: (2011)

Myeloma and marrow adiposity: Unanswered questions and future directions
by: Morris, EV, et al.
Published: (2021)

Glycosphingolipid synthesis inhibition limits osteoclast activation and myeloma bone disease
by: Ersek, A, et al.
Published: (2015)

Cells of the mononuclear phagocyte series differentiate into osteoclastic lacunar bone resorbing cells.
by: Quinn, J, et al.
Published: (1996)

Myeloma cells down-regulate adiponectin in bone marrow adipocytes via TNF-alpha
by: Morris, EV, et al.
Published: (2020)

Agonists of TRAIL death receptors induce myeloma cell apoptosis that is not prevented by cells of the bone marrow microenvironment.
by: Locklin, R, et al.
Published: (2007)

Advances in the management of myeloma bone disease.
by: Shipman, C, et al.
Published: (2005)

Host-derived MMP-7 decreases myeloma progression in vivo: An unexpected role for MMP-7 and osteopontin in myeloma pathogenesis
by: Lwin, S, et al.
Published: (2011)

The ubiquitin-proteasome pathway is dysregulated in myeloma cells in the bone microenvironment in vivo
by: Edwards, C, et al.
Published: (2007)

Wnt signaling: bone's defense against myeloma.
by: Edwards, C
Published: (2008)

Translational potential of a novel osteoclast inhibitor, eliglustat, in myeloma bone disease
by: Leng, H
Published: (2019)

Advances in osteoclast biology: Old findings and new insights from mouse models
by: Edwards, JR, et al.
Published: (2011)

Proteomic characterization of human multiple myeloma bone marrow extracellular matrix
by: Glavey, S V, et al.
Published: (2018)

Novel therapeutic targets in myeloma bone disease.
by: Webb, S, et al.
Published: (2014)

Haematopoietic stem/progenitor cell interactions with the bone marrow vascular niche
by: Chang, CH
Published: (2013)

5T2MM murine myeloma cells and CD138+ve human myeloma cells promote osteoclastic activity rather than osteoclast formation in vitro
by: Mueller, G, et al.
Published: (2004)